Update: Adds company statement about Ozempic availability in the U.S. Novo Nordisk (NVO) has said in a note published by the European Medicines Agency that the supply shortage of its diabetes drug ...

It also provides other contract manufacturing services. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February ...

However, other studies have reached the opposite conclusion. Novo Nordisk's crown jewel is safe for now, and continues to drive its financial results higher. However, various potential headwinds ...

This is especially helpful in biomedicine, where de ... novo protein design and protein optimisation (see Table 1). Some companies, such as Arzeda and AI Proteins, provide a good option for ...

Whether large or small, buy- or sell-focused, organizations focused on growth should explore acquisition and de novo development strategies. Aligning the right and best growth strategy with your ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Biotechnology and pharmaceutical companies are now investing largely in developing innovative technologies for nucleotide synthesis. · For example, in March 2023 Integrated DNA Technologies (IDT) made ...

A contract manufacturing drug organization executive said he believes that Novo Nordisk's (NVO) planned purchase of Catalent (NYSE:CTLT) will spur competition. Beau Garrett, CEO of American ...

[Image courtesy of SoClean] SoClean this week announced it was granted FDA de novo clearance for its at-home CPAP mask and ventilation hose cleaner SoClean 3+. Peterborough, N.H.-based SoClean ...

Experts say Novo Nordisk and Eli Lilly’s GLP-1 drugs are unlikely to reach more countries in the near term, but Sanofi’s diabetes treatment has gained ground globally. Earlier this month, Novo Nordisk ...